ArticleFrontiers in cardiovascular medicine2025
A diagnostic prediction model was established based on the clinical characteristics of multicenter children with Kawasaki disease in Xinjiang.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Kawasaki disease (KD) is a serious pediatric systemic vasculitis that may cause cardiovascular complications, including coronary artery lesions (CAL). This study aimed to evaluate the predictive value of peripheral blood lymphocyte subsets for intravenous immunoglobulin (IVIG) treatment sensitivity in children with KD in Xinjiang. Methods: This multicenter retrospective study collected clinical and laboratory data from 142 children with KD and 120 controls with infectious fever across several hospitals in Xinjiang from June 2022 to December 2024. Peripheral blood lymphocyte subsets and immunoglobulins were analyzed. Multivariate logistic regression was used to identify risk factors for IVIG non-responsiveness, and ROC curve analyses were performed to evaluate diagnostic efficacy. Results: Significant differences in lymphocyte subsets were observed between KD and control groups, including CD3+, CD4+, CD8+, CD19+, and the CD4+/CD8+ ratio. Multivariate logistic regression identified CD4+ cell count as an independent risk factor for IVIG non-responsiveness. ROC analyses suggested that lymphocyte subsets and immunoglobulins (including CD3+, CD+, CD16+CD56+, IgA, and IgM) have diagnostic potential, with CD8+ and CD+ showing high sensitivity and specificity. Discussion: Peripheral blood lymphocyte subsets, particularly CD4+, may serve as useful biomarkers for predicting IVIG treatment response and distinguishing KD from other febrile illnesses. Further studies with larger sample sizes are warranted to refine predictive models and improve KD management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.